Web-based Mindfulness Meditation in Reducing Distress in Participants With Metastatic Gastrointestinal Cancer and Their Caregivers



Status:Active, not recruiting
Healthy:No
Age Range:18 - Any
Updated:4/6/2019
Start Date:April 20, 2018
End Date:December 1, 2019

Use our guide to learn which trials are right for you!

Being Present 2.0: Web-Based Mindfulness Meditation for Gastrointestinal Cancer Patients and Caregivers

This trial studies how well web-based mindfulness meditation works in reducing distress in
both participants with gastrointestinal cancer that has spread to other parts of the body,
and their caregivers. Web-based mindfulness meditation, which uses audio exercises and
interactive webinars taught by trained meditation instructors, may help participants with GI
cancer and their caregivers reduce distress and improve their quality of life.

PRIMARY OBJECTIVES:

I. To determine the feasibility and acceptability of an 8-week web-based mindfulness
meditation program with live webinars among patients with a metastatic gastrointestinal (GI)
cancer receiving chemotherapy and their caregivers.

SECONDARY OBJECTIVES:

I. Estimate the efficacy of an 8-week web-based mindfulness meditation program with live
webinars among patients with a metastatic GI cancer receiving chemotherapy and their
caregivers.

OUTLINE:

Participants practice with web-based mindfulness meditation over 10-15 minute guided audio
sessions for 5 days a week for 8 weeks. Participants also attend meditation webinars over 60
minutes once a week, for 8 weeks.

After completion of study, participants are followed up at 8 weeks.

Inclusion Criteria:

- ELIGIBLE PATIENTS: Carry a diagnosis of a metastatic GI cancer

- ELIGIBLE PATIENTS: Anticipate receiving chemotherapy for at least 12 weeks total from
the time of recruitment

- ELIGIBLE PATIENTS: Have an estimated life expectancy of at least 6 months, assessed by
principal investigator or treating investigator

- ELIGIBLE PATIENTS: Have an Eastern Cooperative Oncology Group (ECOG) performance
status between 0-2

- ELIGIBLE PATIENTS: Be able to speak and read English

- ELIGIBLE PATIENTS: Be able to navigate websites, fill out forms on the web,
communicate by email, and have regular access to the internet (assessed by participant
self-report)

- ELIGIBLE PATIENTS: Have daily access to a mobile phone capable of receiving text
messages, as determined by a study investigator

- ELIGIBLE PATIENTS: Be able to provide informed consent

- ELIGIBLE CAREGIVERS: Be a spouse/partner, other family member, or a close friend of a
patient who consented to participate in the Being Present 2.0 study

- ELIGIBLE CAREGIVERS: Be able to speak and read English

- ELIGIBLE CAREGIVERS: Be able to navigate websites, fill out forms on the web,
communicate by email, and have regular access to the internet (assessed by participant
self-report)

- ELIGIBLE CAREGIVERS: Have access to a mobile phone capable of receiving text messages,
as determined by a study investigator

- ELIGIBLE CAREGIVERS: Be able to provide informed consent

Exclusion Criteria:

- Have a current meditation practice (> 2 episodes or > 1 hour total, weekly)

- Be currently enrolled in a stress reduction program

- Have extensive hearing loss such that ability to participate in the study would be
impaired

- Have participated in the original Being Present pilot study (BP1)

- Be caregivers of patients who decline Being Present 2.0 (BP2) study participation
We found this trial at
1
site
San Francisco, California 94143
Principal Investigator: Chloe E. Atreya
Phone: 877-827-3222
?
mi
from
San Francisco, CA
Click here to add this to my saved trials